Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials.

Publication Type:

Journal Article


Clinical trials (London, England) (2014)


2014, July 2014, Vaccine and Infectious Disease Division


Identifying efficacious interventions for the prevention and treatment of human diseases depends on the efficient development and implementation of controlled clinical trials. Essential to reducing the time and burden of completing the clinical trial lifecycle is determining which aspects take the longest, delay other stages, and may lead to better resource utilization without diminishing scientific quality, safety, or the protection of human subjects.